Commentary

Page 11

Recently published articles about Commentary

Commentary

Potential Interactions of Remdesivir With Psychotropics

May 28, 2020

The FDA has approved remdesivir for severe COVID-19 in children and adults. This commentary reviews potential interactions of remdesivir with psychotropic medications.

Shailesh Jain, Zeeshan Mansuri, Bhumika Shah, et al

Commentary

COVID-19 and Infection Control in the Psychiatric Ward

May 21, 2020

This commentary discusses the challenges faced by health care providers in psychiatric wards during the COVID-19 pandemic.

Mohan Gautam, Gregory Mahr, Shivali Patel

Commentary

Potential Psychiatric Risks of Novel COVID-19 Treatments

May 21, 2020

Various novel pharmacologic treatments are being considered for COVID-19. The authors of this commentary briefly discuss some of these proposed treatments and their possible psychiatric adverse effects.

Jude Chukwuma, Ahmed Saeed Yahya, Shakil Khawaja

Commentary

MDD Treatment: Response to Antidepressants

May 19, 2020

Read commentary on inadequate antidepressant response for MDD. Determining where patients are on the response continuum and managing inadequate response.

George I. Papakostas, W. Clay Jackson, Roueen Rafeyan, et al

Commentary

The Intersection of Suicide and Viral Outbreaks

May 14, 2020

This commentary explores the association between past viral outbreaks and suicide to highlight current and future challenges patients may face in response to the COVID-19 pandemic.

Anjali Thakrar, Esther Akinyemi, Mohan Gautam, et al

Commentary

Challenges in Determining Outcomes of Prenatal Exposure to Antidepressants

May 12, 2020

This commentary notes the findings and implications of a recent study by Rommel et al and discusses possible risks of perinatal antidepressant treatment in light of the need to...

Ruta M. Nonacs, Lee S. Cohen

Commentary

Inclusion of Suicidal Individuals in Research Studies

May 12, 2020

This commentary discusses a recent report by Iltis and colleagues.

Philippe Courtet, Bénédicte Nobile

Commentary

Reinventing Behavioral Health During the COVID-19 Pandemic

May 7, 2020

In this commentary, Dr Pinkhasov discusses the challenges faced by health care providers and the Department of Behavioral Health at NYU Winthrop Hospital during the COVID-19 pandemic.

Aaron Pinkhasov

Commentary

Intimate Partner Violence and COVID-19

May 7, 2020

Could social isolation and fear generated by COVID-19 increase intimate partner violence? This commentary looks at the associations between the COVID-19 crisis and domestic violence and stresses the importance...

Jude Chukwuma, Ahmed Saeed Yahya, Shakil Khawaja

Commentary

Hydroxychloroquine Risks in COVID-19 Patients With Schizophrenia

April 30, 2020

In this commentary, the authors discuss the risks associated with use of hydroxychloroquine in COVID-19-infected patients with schizophrenia.

N. A. Uvais

Commentary

Perspectives on COVID-19 and Individuals With Serious Mental Illness

April 28, 2020

Although the COVID-19 pandemic has impacted everyone in some way, those with serious mental illness (SMI) may face unique challenges. This commentary looks at the consequences of both the...

Ann K. Shinn, Mark Viron

Commentary

The Impact of COVID-19 in Psychiatry

April 16, 2020

In this commentary, the authors discuss the impact of COVID-19 on those with mental illness and in the field of psychiatry.

Jude Chukwuma, Ahmed Saeed Yahya, Shakil Khawaja

« 1 … 9 10 11 12 13 … 28 »